News articles about iKang Healthcare Group (NASDAQ:KANG) have been trending somewhat positive recently, according to Accern Sentiment. The research group rates the sentiment of press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. iKang Healthcare Group earned a media sentiment score of 0.18 on Accern’s scale. Accern also assigned media stories about the medical research company an impact score of 47.8548385591445 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Separately, BidaskClub upgraded shares of iKang Healthcare Group from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 5th.

iKang Healthcare Group (NASDAQ KANG) opened at 13.65 on Friday. iKang Healthcare Group has a 52-week low of $11.70 and a 52-week high of $18.67.

iKang Healthcare Group (NASDAQ:KANG) last released its earnings results on Thursday, September 14th. The medical research company reported $0.06 EPS for the quarter. iKang Healthcare Group had a negative net margin of 2.16% and a negative return on equity of 2.68%. The firm had revenue of $115.60 million for the quarter. On average, analysts predict that iKang Healthcare Group will post $0.65 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This report was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another publication, it was copied illegally and republished in violation of US and international trademark and copyright law. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/10/06/ikang-healthcare-group-kang-earns-media-impact-rating-of-0-18.html.

iKang Healthcare Group Company Profile

iKang Healthcare Group, Inc provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services.

Insider Buying and Selling by Quarter for iKang Healthcare Group (NASDAQ:KANG)

Receive News & Stock Ratings for iKang Healthcare Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group Inc. and related stocks with our FREE daily email newsletter.